Gauss Surgical Receives CE Mark Approval for Triton

Los Altos, Calif., November 4, 2015 – Gauss Surgical, Inc. announced today that the company has received CE (Conformité Européenne) Mark for its Triton System™ for iPad, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. This milestone allows Gauss to market and sell its system throughout Europe and other regions that require the CE Mark.

Gauss Surgical to Present Triton at UHC Annual Conference

Los Altos, Calif., September 29, 2015 – Gauss Surgical, Inc. announced today that the company will compete in the annual “UHC Startup Challenge”, which will take place on Friday, October 2 in Orlando as part of the “Advance: UHC Annual Conference 2015”. The company will have the opportunity to present Triton, the world’s first and only mobile platform for real-time monitoring of surgical blood loss, to the nearly 2,000 health care professionals in attendance.

Gauss Surgical Completes $12 Million Series A Financing; Proceeds To Propel Commercial Growth of World’s First Mobile Platform to Monitor Surgical Blood Loss

Los Altos, Calif., August 26, 2015 – Gauss Surgical, Inc. announced today that the company has completed series A financing to accelerate sales growth and further commercialization of the Triton System™, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. The latest round was led by Promus Ventures and joined by Summation Health Ventures and LifeForce Ventures.

Gauss Surgical Announces FDA 510(k) Clearance of Triton Canister App for Accurate Surgical Blood Loss Monitoring

Los Altos, Calif., March 16, 2015 – Gauss Surgical today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Triton Canister App, the second core product in its Triton System™ portfolio, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. Now, in addition to estimating blood loss on surgical sponges, the system can accurately estimate blood loss in blood bearing canisters, giving clinicians a better picture of overall surgical blood loss.

First Purchase of Triton Fluid Management System for Burn Center Use

Los Altos, Calif., February 25, 2015 – Gauss Surgical today announced that UC Irvine Medical Center in Orange, Calif., has purchased the Triton Fluid Management System™, the world’s first and only mobile platform for real-time estimation of surgical blood loss on surgical sponges. The Center will use the Triton System within its UC Irvine Health Regional Burn Center to estimate blood loss during surgeries for patients with burn injuries.

Cedars-Sinai First to Purchase Gauss Surgical’s Triton System™ for Real-Time Assessment of Surgical Blood Loss

Los Altos, Calif., Nov.11, 2014 – Gauss Surgical today announced that Cedars-Sinai Medical Center in Los Angeles, the largest academic medical center in the western United States, is the first institution to purchase the Triton Fluid Management System™. Triton is the world’s first and only mobile platform for real-time assessment of blood loss on surgical sponges. In addition, Cedars-Sinai will partner with Gauss Surgical to further explore the role of the technology in improving patient outcomes and reducing unnecessary blood transfusions and their associated costs and complications.

First Patient Cases Completed Using Triton Fluid Management from Gauss Surgical

Los Altos, Calif., August 26, 2014 – Gauss Surgical today announced that the first patient cases were completed using the Triton Fluid Management System™ at Magee-Womens Hospital of the University of Pittsburgh Medical Center (UPMC) in Pittsburgh, Pa. The Triton System eliminates the need for visual estimation by providing accurate estimates of blood loss on surgical sponges during surgery.

Gauss Surgical Announces FDA Clearance of the First Mobile Platform for Real-Time Estimation of Surgical Blood Loss

Gauss Surgical Announces FDA Clearance of the First Mobile Platform for Real-Time Estimation of Surgical Blood Loss

Los Altos, Calif., May 20, 2014 – Gauss Surgical today announced that the Triton Fluid Management System™, the world’s first and only mobile platform for real-time estimation of surgical blood loss on surgical sponges, has received U.S. Food and Drug Administration (FDA) approval. Triton provides physicians a first of its kind device to accurately estimate intra-operative blood loss through the use of sophisticated cloud-based computer vision algorithms to estimate blood loss and hemoglobin mass on surgical sponges.